Using various pharmacological and genetic gain- or loss-of-function approaches, we demonstrated that PDE4D haploinsufficiency or pharmacological inhibition can improve cardiomyocyte hypertrophy and HF by promoting PINK1/Parkin-mediated cardiac mitophagy via CREB-SIRT1 signaling pathway (Fig. 8). Here, PRKN is linked to hydrops fetalis.